chr10-110112885-T-C
Variant names: 
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_016824.5(ADD3):c.304T>C(p.Ser102Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00229 in 1,613,978 control chromosomes in the GnomAD database, including 55 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
 Genomes: 𝑓 0.011   (  25   hom.,  cov: 32) 
 Exomes 𝑓:  0.0014   (  30   hom.  ) 
Consequence
 ADD3
NM_016824.5 missense
NM_016824.5 missense
Scores
 1
 6
 11
Clinical Significance
Conservation
 PhyloP100:  3.08  
Publications
5 publications found 
Genes affected
 ADD3  (HGNC:245):  (adducin 3) Adducins are heteromeric proteins composed of different subunits referred to as adducin alpha, beta and gamma. The three subunits are encoded by distinct genes and belong to a family of membrane skeletal proteins involved in the assembly of spectrin-actin network in erythrocytes and at sites of cell-cell contact in epithelial tissues. While adducins alpha and gamma are ubiquitously expressed, the expression of adducin beta is restricted to brain and hematopoietic tissues. Adducin, originally purified from human erythrocytes, was found to be a heterodimer of adducins alpha and beta. Polymorphisms resulting in amino acid substitutions in these two subunits have been associated with the regulation of blood pressure in an animal model of hypertension. Heterodimers consisting of alpha and gamma subunits have also been described. Structurally, each subunit is comprised of two distinct domains. The amino-terminal region is protease resistant and globular in shape, while the carboxy-terminal region is protease sensitive. The latter contains multiple phosphorylation sites for protein kinase C, the binding site for calmodulin, and is required for association with spectrin and actin. Alternatively spliced adducin gamma transcripts encoding different isoforms have been described. The functions of the different isoforms are not known. [provided by RefSeq, Jul 2008] 
ADD3 Gene-Disease associations (from GenCC):
- cerebral palsy, spastic quadriplegic, 3Inheritance: AR Classification: STRONG, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
 - complex neurodevelopmental disorder with motor featuresInheritance: AR Classification: MODERATE Submitted by: ClinGen
 - spastic quadriplegic cerebral palsyInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
 
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.0044383705). 
BP6
Variant 10-110112885-T-C is Benign according to our data. Variant chr10-110112885-T-C is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 376951.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. 
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.0113 (1715/152326) while in subpopulation AFR AF = 0.0387 (1607/41578). AF 95% confidence interval is 0.0371. There are 25 homozygotes in GnomAd4. There are 784 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check. 
BS2
High Homozygotes in GnomAd4 at 25 AR gene
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes   AF:  0.0112  AC: 1711AN: 152208Hom.:  25  Cov.: 32 show subpopulations 
GnomAD3 genomes 
 AF: 
AC: 
1711
AN: 
152208
Hom.: 
Cov.: 
32
Gnomad AFR 
 AF: 
Gnomad AMI 
 AF: 
Gnomad AMR 
 AF: 
Gnomad ASJ 
 AF: 
Gnomad EAS 
 AF: 
Gnomad SAS 
 AF: 
Gnomad FIN 
 AF: 
Gnomad MID 
 AF: 
Gnomad NFE 
 AF: 
Gnomad OTH 
 AF: 
GnomAD2 exomes  AF:  0.00316  AC: 794AN: 251108 AF XY:  0.00229   show subpopulations 
GnomAD2 exomes 
 AF: 
AC: 
794
AN: 
251108
 AF XY: 
Gnomad AFR exome 
 AF: 
Gnomad AMR exome 
 AF: 
Gnomad ASJ exome 
 AF: 
Gnomad EAS exome 
 AF: 
Gnomad FIN exome 
 AF: 
Gnomad NFE exome 
 AF: 
Gnomad OTH exome 
 AF: 
GnomAD4 exome  AF:  0.00136  AC: 1987AN: 1461652Hom.:  30  Cov.: 31 AF XY:  0.00122  AC XY: 889AN XY: 727126 show subpopulations 
GnomAD4 exome 
 AF: 
AC: 
1987
AN: 
1461652
Hom.: 
Cov.: 
31
 AF XY: 
AC XY: 
889
AN XY: 
727126
show subpopulations 
African (AFR) 
 AF: 
AC: 
1406
AN: 
33462
American (AMR) 
 AF: 
AC: 
129
AN: 
44650
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
24
AN: 
26128
East Asian (EAS) 
 AF: 
AC: 
0
AN: 
39684
South Asian (SAS) 
 AF: 
AC: 
25
AN: 
86214
European-Finnish (FIN) 
 AF: 
AC: 
0
AN: 
53418
Middle Eastern (MID) 
 AF: 
AC: 
35
AN: 
5766
European-Non Finnish (NFE) 
 AF: 
AC: 
179
AN: 
1111942
Other (OTH) 
 AF: 
AC: 
189
AN: 
60388
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.475 
Heterozygous variant carriers
 0 
 95 
 190 
 286 
 381 
 476 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
 0 
 48 
 96 
 144 
 192 
 240 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
GnomAD4 genome   AF:  0.0113  AC: 1715AN: 152326Hom.:  25  Cov.: 32 AF XY:  0.0105  AC XY: 784AN XY: 74488 show subpopulations 
GnomAD4 genome 
 AF: 
AC: 
1715
AN: 
152326
Hom.: 
Cov.: 
32
 AF XY: 
AC XY: 
784
AN XY: 
74488
show subpopulations 
African (AFR) 
 AF: 
AC: 
1607
AN: 
41578
American (AMR) 
 AF: 
AC: 
77
AN: 
15302
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
3
AN: 
3470
East Asian (EAS) 
 AF: 
AC: 
0
AN: 
5186
South Asian (SAS) 
 AF: 
AC: 
0
AN: 
4826
European-Finnish (FIN) 
 AF: 
AC: 
0
AN: 
10616
Middle Eastern (MID) 
 AF: 
AC: 
2
AN: 
294
European-Non Finnish (NFE) 
 AF: 
AC: 
13
AN: 
68028
Other (OTH) 
 AF: 
AC: 
13
AN: 
2114
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.500 
Heterozygous variant carriers
 0 
 88 
 175 
 263 
 350 
 438 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
 0 
 22 
 44 
 66 
 88 
 110 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
Alfa 
 AF: 
Hom.: 
Bravo 
 AF: 
TwinsUK 
 AF: 
AC: 
1
ALSPAC 
 AF: 
AC: 
2
ESP6500AA 
 AF: 
AC: 
160
ESP6500EA 
 AF: 
AC: 
2
ExAC 
 AF: 
AC: 
474
Asia WGS 
 AF: 
AC: 
7
AN: 
3478
EpiCase 
 AF: 
EpiControl 
 AF: 
ClinVar
Significance: Benign/Likely benign 
Submissions summary: Benign:3 
Revision: criteria provided, multiple submitters, no conflicts
LINK: link 
Submissions by phenotype
not provided    Benign:3 
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Dec 30, 2016
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Jan 27, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source: 
Name
Calibrated prediction
Score
Prediction
 AlphaMissense 
 Benign 
 BayesDel_addAF 
 Benign 
T 
 BayesDel_noAF 
 Benign 
 DANN 
 Uncertain 
 DEOGEN2 
 Benign 
.;T;. 
 Eigen 
 Uncertain 
 Eigen_PC 
 Uncertain 
 FATHMM_MKL 
 Pathogenic 
D 
 LIST_S2 
 Uncertain 
.;D;D 
 MetaRNN 
 Benign 
T;T;T 
 MetaSVM 
 Benign 
T 
 MutationAssessor 
 Uncertain 
M;M;M 
 PhyloP100 
 PrimateAI 
 Uncertain 
T 
 PROVEAN 
 Benign 
N;N;N 
 REVEL 
 Benign 
 Sift 
 Benign 
T;T;T 
 Sift4G 
 Benign 
T;T;T 
 Polyphen 
D;P;D 
 Vest4 
 MVP 
 MPC 
 0.37 
 ClinPred 
T 
 GERP RS 
 Varity_R 
 gMVP 
Splicing
Name
Calibrated prediction
Score
Prediction
 SpliceAI score (max) 
Details are displayed if max score is > 0.2
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at 
Publications
 You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.